Gut microbiome and depression: How microbes affect the way we think
The CNP Microbiota-Gut-Brain Axis (MGBA) & Mental Health Research Category consolidates research exploring the interconnected relationship between dietary intake, the microbiome, and the gut-brain axis in the adult population. To view each original study on the open internet, click “Original.” To view the CNP-written abstract summary, click “CNP Summary.” While only some of the CNP-written abstract summaries are available below for free, all abstract summaries are available to CNP members through the CNP Library Membership.
Major depressive disorder (MDD), being a complicated condition in nature, affects 280 million individuals globally and is a primary cause of disability. Numerous environmental variables, including medicines, nutrition, and microorganisms, have a role in the pathophysiology of depression disorders. The host immune system, genetics, and epigenetics are some of the contributors to the intricate underlying causes of depression. Alterations to intestinal microbiota and their metabolites affect how people with depressive disorders respond to stress and behave in social situations by influencing immune cell maturation and brain neurogenesis, which is mediated by epigenetic changes. In this study, Nohesara et al. (2023) address the possible contributions of dysregulated gut permeability to the emergence of depressive illnesses through changes in metabolites generated from the gut microbiota that have epigenetic consequences. In addition, the authors discuss how changes in the makeup of the gut microbiota might lead to epigenetic changes that can cause depressive illnesses. Focus is shed on the potential benefits of microbiota-derived metabolites, such as probiotics, butyrate (which acts as an epigenetic modifier), polyphenols, medications (such as antibiotics, antipsychotics, and antidepressants), maternal diet, and fecal microbiota transplantation, in mitigating depressive-like behaviors through altering the epigenetic landscape. Lastly, the authors review the difficulties and potential solutions connected to current treatment techniques for depressive disorders via microbiome-related epigenetic changes.
Gut microbiome and depression: How microbes affect the way we think
The microbiota-gut-brain axis: neurobehavioral correlates, health and sociality
Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis
CNP Research Summary can be found in the CNP Library Membership
The role of inflammation and the gut microbiome in depression and anxiety
Microbes and mental health: A review
Gut-brain psychology: Rethinking psychology from the microbiota–gut–brain axis
Targeting the microbiota, from irritable bowel syndrome to mood disorders: focus on probiotics and prebiotics
CNP Research Summary can be found in the CNP Library Membership
Measuring the brain-gut axis in psychological sciences: A necessary challenge
“I am I and my bacterial circumstances”: Linking gut microbiome, neurodevelopment, and depression
CNP Research Summary can be found in the CNP Library Membership